Skip to content

Peroxisome Biogenesis Disorder Complementation Group 6 C1832231

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder that impairs peroxisome function, which is essential for processing fatty acids. This can result in developmental delays, vision and hearing loss, and seizures. Treatment aims to manage complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Sensorineural hearing loss

(otologic)

Adrenal insufficiency

(endocrine)

Renal cysts

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Multi-System Monitoring

Regular monitoring of hepatic function, neurological development, and vision/hearing status through a coordinated specialist team. Includes periodic laboratory testing and imaging to track disease progression and organ involvement.

monitoring
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Specialized Metabolic Diet

Implementation of dietary interventions including phytanic acid restriction and careful management of very long chain fatty acid (VLCFA) intake through modified food selections to support metabolic function.

dietary

Additional treatment options

Developmental Physical Therapy

Structured physical therapy program addressing motor delays, hypotonia, and spasticity through targeted exercises, positioning, and adaptive techniques to maximize functional mobility.

physical_therapy

Symptomatic Seizure Management

Anticonvulsant therapy for seizure control using appropriate anti-epileptic medications as prescribed by a neurologist, with regular review of efficacy and side effects.

medication

Neurodevelopmental Support Services

Psychological and educational support services including cognitive assessment, behavioral interventions, and family counseling to address developmental challenges and improve quality of life.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Peroxisome Biogenesis Disorder Complementation Group 6 C1832231?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Steinberg SJ, Moser AB, Raymond GV. Clinical practice guidelines for peroxisome biogenesis disorders. J Inherit Metab Dis. 2020.

guideline2020
2

Waterham HR, Ebberink MS, Steinberg SJ. Novel therapeutic approaches for peroxisome biogenesis disorders. Mol Genet Metab. 2022.

clinical_trial2022
3

Fujiki Y, Okumoto K, Mukai S. Molecular basis of peroxisome biogenesis defects in complementation group 6. Biochim Biophys Acta. 2019.

review2019
4

Braverman NE, Steinberg SJ. Diagnosis and management of Zellweger spectrum disorders. Clin Genet. 2021.

review2021

Medication Comparisons

Compare medications used to treat Peroxisome Biogenesis Disorder Complementation Group 6 C1832231. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy